Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in active non-radiographic axial spondyloarthritis
NCT01453725Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of golimumab in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by Merck & Co.. Started Feb 2012; status: completed.
02
Drugs
golimumab
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT01453725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453725.